Craneware plc (LON:CRW - Get Free Report) insider Will Whitehorn purchased 1,911 shares of the company's stock in a transaction that occurred on Thursday, April 24th. The shares were purchased at an average cost of GBX 1,584 ($21.04) per share, with a total value of £30,270.24 ($40,215.54).
Craneware Price Performance
Shares of LON:CRW traded up GBX 20 ($0.27) during midday trading on Thursday, hitting GBX 1,820 ($24.18). The stock had a trading volume of 301,543 shares, compared to its average volume of 88,447. The company's 50-day moving average price is GBX 1,726.34 and its 200-day moving average price is GBX 1,969.56. Craneware plc has a fifty-two week low of GBX 1,330 ($17.67) and a fifty-two week high of GBX 2,509.20 ($33.34). The company has a quick ratio of 1.00, a current ratio of 0.63 and a debt-to-equity ratio of 12.22. The company has a market capitalization of £781.99 million, a P/E ratio of 67.24 and a beta of 0.28.
Craneware Cuts Dividend
The company also recently disclosed a dividend, which was paid on Thursday, April 17th. Shareholders of record on Thursday, March 20th were given a dividend of GBX 13.50 ($0.18) per share. The ex-dividend date of this dividend was Thursday, March 20th. This represents a yield of 0.71%. Craneware's dividend payout ratio is currently 107.14%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on CRW shares. Berenberg Bank reiterated a "buy" rating and issued a GBX 2,800 ($37.20) price target on shares of Craneware in a research note on Tuesday, March 11th. Shore Capital reiterated a "buy" rating on shares of Craneware in a research report on Tuesday, March 11th.
Check Out Our Latest Research Report on CRW
About Craneware
(
Get Free Report)
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
Recommended Stories
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
